70-H6901-26-CP417_10022026 Fresnius Medical Care SS.pdf.PDF

UNM Proposed Sole Source Form – Rev 04/07/2021

Proposed Sole Source Purchase Form Pursuant to New Mexico Procurement law, the UNM Purchasing Department will post your completed form on the UNM Sunshine Portal and the

State of New Mexico Procurement website for 30 days prior to purchase of the goods/services.

I. GENERAL INFORMATION. PLEASE PROVIDE THE FOLLOWING:

Date of Request 10/2/2026 Requisition Number (If Applicable) Request Submitted by: Megan Prinz Title Unit Director

Department Dialysis Email marbenavidez@salud.unm.edu Phone 505-925-4387 Proposed Vendor Fresnius Medical Care Amount $ 494,000

Vendor Address 920 Winter Street Waltham, MA 02451 Term of Purchase Single Capital Purchase plus disposables. 1yr.

W/renewals consistent with the NM Procurement Code

Buyer Team - See Commodity list at http://purchase.unm.edu/department-information/comm-code-listing.pdf

Provide a basic description of goods/services to be provided:

Hemodialysis machine. AquaC Uno H Dialysis Water Treatment System. The AquaC UNO H Portable Water Purification System is a reverse osmosis unit intended for use with hemodialysis systems to remove organic and inorganic substances and microbial contaminants from the water used for treating hemodialysis patients or related therapies. The Fresenius Medical Care 2008T BlueStar™ Hemodialysis Machine is a hemodialysis delivery system designed for acute and chronic dialysis therapy in healthcare facilities

Why is this purchase needed?

Needed to provide care to adult & pediatric patients, current system is nearing the end of life.

II. BASIS FOR SOLE SOURCE PROCUREMENT. CHOOSE APPLICABLE BOX(ES) AND

PROVIDE ADDITIONAL INFORMATION, AS REQUESTED:

☐ Proprietary item, technology or service only available from the proposed vendor. (Check box and describe proprietary component)

The AquaC -disinfection capability------including the membrane and permeate ring------allowing disinfection with hot water rather than chemical disinfectants.

Automated rinse and standby-heat functions can reduce staff involvement and help streamline daily operation.

Fresenius identifies up to 70% water recovery with intelligent parameter controls, depending on operating conditions.

No preventative-maintenance kits, two-year preventative maintenance intervals, and no calibration requirement.

Designed to support a broad range of patients and clinical applications within the acute-care and chronic-care environment. In addition to standard hemodialysis, the machine supports isolated UF, SLED, and low-volume hemodialysis for patients for extended treatment sessions of up to 12 hours.

The machine incorporates automated technologies designed to reduce the number of manual steps required during treatment.

Idle Mode designed to reduce dialysate and water consumption when the machine is temporarily not actively treating. Fresenius reports that Idle Mode can reduce dialysate and water usage by up to two-thirds.

Can perform an Independent Conductivity and pH Self-Test, using the post-dialyzer conductivity cell as an independent conductivity check and automatically checking pH when the optional bibag® On-line Dry Bicarbonate Concentrate system is being used.

Optional bibag system provides an alternative to traditional liquid bicarbonate concentrate. The dry bicarbonate concentrate is lightweight and can streamline bicarbonate handling and storage.

Optional Crit-Line® Monitoring System provides continuous, non-invasive monitoring of hematocrit, oxygen saturation, and blood volume changes during treatment to help clinicians make informed ultrafiltration decisions in real time.

☐ Compatibility requirement with existing item, technology or service. (Check box and describe compatibility requirement)

☐ Renewal of support/maintenance/subscription of software, technology or other intellectual property. (Check box and describe)

☒ Other Basis for Sole Source: Please describe below:

The only machine that can accommodate low-weight, low-volume patients in our pediatric population. Fresenius Medical Care is the Original Equipment Manufacturer (OEM) and the sole source for new 2008® series hemodialysis machines, Clinical Data eXchange™ (CDX), bibag®, CLiC™ devices and associated spare parts. This is to confirm that Fresenius Medical Care is the Original Equipment Manufacturer (OEM) and the sole source for the AquaBplus™, AquaA™ and AquaC UNO H™ Dialysis Water Treatment Systems including associated spare parts in the US.

III. SUPPLEMENTAL DETAILS. PLEASE PROVIDE ADDITIONAL INFORMATION AS

REQUESTED BELOW:

Describe in detail the unique capabilities of the proposed vendor’s goods/service and/or personnel performing the work and why this constitutes the only source. Focus on what is unique about the goods/service and why no other vendor could meet your needs.

The AquaC UNO H is an RO component, not a complete water-treatment system; appropriate pretreatment and, when required, post-treatment are still necessary to meet applicable standards. All optional components listed on quote provided.

The Fresenius machines are the only machines available right now that can handle the low weight and low blood volume of our pediatric patients. We need this equipment to safely provide dialysis to our smaller pediatric patients, and no other vendor currently has what we need.

Describe the due diligence made to locate other possible sources including communications with other universities, communications with similar providers, web searches, yellow page searches, review of advertisements and trade publications, etc.

We reviewed available dialysis equipment and researched other companies that provide dialysis machines for pediatric patients. We also reached out to other healthcare equipment providers and compared the options available.

This review did not identify another source that could meet our specific needs.

List the other vendors who were contacted. Please describe the specs/qualifications/criteria that the other vendors were unable to satisfy.

We contacted other dialysis vendors, including Vantive and B. Braun, to see if they had a machine that would work for our pediatric patients. We also looked at the equipment and options they currently offer. At this time, we were unable to find another vendor that can meet the needs of our low-weight, low-volume pediatric patients.

Approved: _________________________________________________ Date: ___________________________ Jeffrey Gilmore (Oct 2, 2026 14:29:04 MDT) Jeffrey Gilmore (Oct 2, 2026 14:29:04 MDT)